Leonardo Gomes da Fonseca

25PUBLICATIONS
145CO-AUTHORS
Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Nov 12, 2025
Prognostic value of a simplified score based on routine parameters in patients with hepatocellular carcinoma treated with systemic therapies: a retrospective cohort study.

Leonardo G Da Fonseca, Thamires Haick Martins da Silveira, Victor Junji Yamamoto

|Aug 12, 2025
Breaking Barriers for Intensive Care Admission in Patients With Advanced HCC on Immunotherapy.

Marta Fortuny, Leonardo G da Fonseca, Manon Allaire

|Jul 30, 2025
Effectiveness and Safety of Immunotherapy for Hepatocellular Carcinoma in Clinical Practice: A Brazilian Multicenter Study.

Leonardo Gomes da Fonseca, Cecília Souza Freire, Rodrigo Antonio Vieira Guedes

|Apr 10, 2025
Hepatic Recompensation Before Systemic Therapy for Hepatocellular Carcinoma Yields Comparable Survival to Compensated Cirrhosis.

Federico Piñero, Margarita Anders, Carla Bermudez

|Nov 26, 2024
Real-World, Observational, Retrospective Study to Evaluate the Effectiveness and Safety of Treatment with Sorafenib in Patients with Advanced Hepatocellular Carcinoma.

Angélica Richart Csipak, Leonardo G da Fonseca, Rossana Verónica Mendoza López

|Nov 07, 2023
Treatment Outcomes in Patients with Advanced Fibrolamellar Hepatocellular Carcinoma Under Systemic Treatment: Analysis of Clinical Characteristics, Management, and Radiomics.

Leonardo G Da Fonseca, Victor Junji Yamamoto, Mateus Trinconi Cunha

Pageof 5